カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の関節リウマチ用医薬品市場予測2023-2029：医療用医薬品、一般用医薬品

【英語タイトル】Rheumatoid Arthritis Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8637）・商品コード：MMG23LY8637
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：79
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の関節リウマチ用医薬品市場規模と予測を収録しています。・世界の関節リウマチ用医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の関節リウマチ用医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の関節リウマチ用医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療用医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

関節リウマチ用医薬品のグローバル主要企業は、AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Coなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、関節リウマチ用医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の関節リウマチ用医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の関節リウマチ用医薬品市場：タイプ別市場シェア、2022年
・医療用医薬品、一般用医薬品

世界の関節リウマチ用医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の関節リウマチ用医薬品市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の関節リウマチ用医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の関節リウマチ用医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における関節リウマチ用医薬品のグローバル売上、2018年-2023年
・主要企業における関節リウマチ用医薬品のグローバル売上シェア、2022年
・主要企業における関節リウマチ用医薬品のグローバル販売量、2018年-2023年
・主要企業における関節リウマチ用医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Co

*************************************************************

・調査・分析レポートの概要
関節リウマチ用医薬品市場の定義
市場セグメント
世界の関節リウマチ用医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の関節リウマチ用医薬品市場規模
世界の関節リウマチ用医薬品市場規模：2022年 VS 2029年
世界の関節リウマチ用医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの関節リウマチ用医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の関節リウマチ用医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医療用医薬品、一般用医薬品
関節リウマチ用医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
関節リウマチ用医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別関節リウマチ用医薬品市場規模 2022年と2029年
地域別関節リウマチ用医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Co
...

Rheumatoid Arthritis is an autoimmune disease that causes pain, swelling, and stiffness in the joints, and may cause severe joint damage, loss of function, and disability. The disease may last from months to a lifetime, and symptoms may improve and worsen over time.
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Medicine. This report contains market size and forecasts of Rheumatoid Arthritis Medicine in global, including the following market information:
Global Rheumatoid Arthritis Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rheumatoid Arthritis Medicine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rheumatoid Arthritis Medicine companies in 2022 (%)
The global Rheumatoid Arthritis Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prescription Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Medicine include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Medicine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, by Type, 2022 (%)
Prescription Drugs
OTC Drugs
Global Rheumatoid Arthritis Medicine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Others
Global Rheumatoid Arthritis Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Medicine revenues share in global market, 2022 (%)
Key companies Rheumatoid Arthritis Medicine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rheumatoid Arthritis Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Hoffman-La Roche AG
Amgen Inc
Pfizer Inc
Bristol-Myers Squibb Co
Johnson & Johnson
UCB Biosciences Inc
Mitsubishi Tanabe Pharma Corp
Biogen Inc
Merck & Co
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatoid Arthritis Medicine, market overview.
Chapter 2: Global Rheumatoid Arthritis Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatoid Arthritis Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rheumatoid Arthritis Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis Medicine Overall Market Size
2.1 Global Rheumatoid Arthritis Medicine Market Size: 2022 VS 2029
2.2 Global Rheumatoid Arthritis Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rheumatoid Arthritis Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Rheumatoid Arthritis Medicine Players in Global Market
3.2 Top Global Rheumatoid Arthritis Medicine Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Medicine Revenue by Companies
3.4 Global Rheumatoid Arthritis Medicine Sales by Companies
3.5 Global Rheumatoid Arthritis Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rheumatoid Arthritis Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rheumatoid Arthritis Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Players in Global Market
3.8.1 List of Global Tier 1 Rheumatoid Arthritis Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Rheumatoid Arthritis Medicine Market Size Markets, 2022 & 2029
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type – Global Rheumatoid Arthritis Medicine Revenue & Forecasts
4.2.1 By Type – Global Rheumatoid Arthritis Medicine Revenue, 2018-2023
4.2.2 By Type – Global Rheumatoid Arthritis Medicine Revenue, 2024-2029
4.2.3 By Type – Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Rheumatoid Arthritis Medicine Sales & Forecasts
4.3.1 By Type – Global Rheumatoid Arthritis Medicine Sales, 2018-2023
4.3.2 By Type – Global Rheumatoid Arthritis Medicine Sales, 2024-2029
4.3.3 By Type – Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Rheumatoid Arthritis Medicine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Rheumatoid Arthritis Medicine Revenue & Forecasts
5.2.1 By Application – Global Rheumatoid Arthritis Medicine Revenue, 2018-2023
5.2.2 By Application – Global Rheumatoid Arthritis Medicine Revenue, 2024-2029
5.2.3 By Application – Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Rheumatoid Arthritis Medicine Sales & Forecasts
5.3.1 By Application – Global Rheumatoid Arthritis Medicine Sales, 2018-2023
5.3.2 By Application – Global Rheumatoid Arthritis Medicine Sales, 2024-2029
5.3.3 By Application – Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Rheumatoid Arthritis Medicine Market Size, 2022 & 2029
6.2 By Region – Global Rheumatoid Arthritis Medicine Revenue & Forecasts
6.2.1 By Region – Global Rheumatoid Arthritis Medicine Revenue, 2018-2023
6.2.2 By Region – Global Rheumatoid Arthritis Medicine Revenue, 2024-2029
6.2.3 By Region – Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Rheumatoid Arthritis Medicine Sales & Forecasts
6.3.1 By Region – Global Rheumatoid Arthritis Medicine Sales, 2018-2023
6.3.2 By Region – Global Rheumatoid Arthritis Medicine Sales, 2024-2029
6.3.3 By Region – Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Rheumatoid Arthritis Medicine Revenue, 2018-2029
6.4.2 By Country – North America Rheumatoid Arthritis Medicine Sales, 2018-2029
6.4.3 US Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.4.4 Canada Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.4.5 Mexico Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Rheumatoid Arthritis Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Rheumatoid Arthritis Medicine Sales, 2018-2029
6.5.3 Germany Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.4 France Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.5 U.K. Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.6 Italy Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.7 Russia Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.5.9 Benelux Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Rheumatoid Arthritis Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Rheumatoid Arthritis Medicine Sales, 2018-2029
6.6.3 China Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.6.4 Japan Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.6.5 South Korea Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.6.7 India Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Rheumatoid Arthritis Medicine Revenue, 2018-2029
6.7.2 By Country – South America Rheumatoid Arthritis Medicine Sales, 2018-2029
6.7.3 Brazil Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.7.4 Argentina Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Rheumatoid Arthritis Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Rheumatoid Arthritis Medicine Sales, 2018-2029
6.8.3 Turkey Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.8.4 Israel Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Rheumatoid Arthritis Medicine Market Size, 2018-2029
6.8.6 UAE Rheumatoid Arthritis Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.1.4 AbbVie Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Inc Key News & Latest Developments
7.2 Hoffman-La Roche AG
7.2.1 Hoffman-La Roche AG Company Summary
7.2.2 Hoffman-La Roche AG Business Overview
7.2.3 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Major Product Offerings
7.2.4 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Hoffman-La Roche AG Key News & Latest Developments
7.3 Amgen Inc
7.3.1 Amgen Inc Company Summary
7.3.2 Amgen Inc Business Overview
7.3.3 Amgen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.3.4 Amgen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Amgen Inc Key News & Latest Developments
7.4 Pfizer Inc
7.4.1 Pfizer Inc Company Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.4.4 Pfizer Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Inc Key News & Latest Developments
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Company Summary
7.5.2 Bristol-Myers Squibb Co Business Overview
7.5.3 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Major Product Offerings
7.5.4 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Bristol-Myers Squibb Co Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Rheumatoid Arthritis Medicine Major Product Offerings
7.6.4 Johnson & Johnson Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 UCB Biosciences Inc
7.7.1 UCB Biosciences Inc Company Summary
7.7.2 UCB Biosciences Inc Business Overview
7.7.3 UCB Biosciences Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.7.4 UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.7.5 UCB Biosciences Inc Key News & Latest Developments
7.8 Mitsubishi Tanabe Pharma Corp
7.8.1 Mitsubishi Tanabe Pharma Corp Company Summary
7.8.2 Mitsubishi Tanabe Pharma Corp Business Overview
7.8.3 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.8.5 Mitsubishi Tanabe Pharma Corp Key News & Latest Developments
7.9 Biogen Inc
7.9.1 Biogen Inc Company Summary
7.9.2 Biogen Inc Business Overview
7.9.3 Biogen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.9.4 Biogen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.9.5 Biogen Inc Key News & Latest Developments
7.10 Merck & Co
7.10.1 Merck & Co Company Summary
7.10.2 Merck & Co Business Overview
7.10.3 Merck & Co Rheumatoid Arthritis Medicine Major Product Offerings
7.10.4 Merck & Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2018-2023)
7.10.5 Merck & Co Key News & Latest Developments
8 Global Rheumatoid Arthritis Medicine Production Capacity, Analysis
8.1 Global Rheumatoid Arthritis Medicine Production Capacity, 2018-2029
8.2 Rheumatoid Arthritis Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Rheumatoid Arthritis Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rheumatoid Arthritis Medicine Supply Chain Analysis
10.1 Rheumatoid Arthritis Medicine Industry Value Chain
10.2 Rheumatoid Arthritis Medicine Upstream Market
10.3 Rheumatoid Arthritis Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Rheumatoid Arthritis Medicine in Global Market
Table 2. Top Rheumatoid Arthritis Medicine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rheumatoid Arthritis Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rheumatoid Arthritis Medicine Revenue Share by Companies, 2018-2023
Table 5. Global Rheumatoid Arthritis Medicine Sales by Companies, (K Units), 2018-2023
Table 6. Global Rheumatoid Arthritis Medicine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rheumatoid Arthritis Medicine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Rheumatoid Arthritis Medicine Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2018-2023
Table 15. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2024-2029
Table 16. By Application – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2018-2023
Table 20. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2024-2029
Table 21. By Region – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2018-2023
Table 25. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2024-2029
Table 26. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2018-2023
Table 29. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2024-2029
Table 38. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2018-2023
Table 41. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2024-2029
Table 46. AbbVie Inc Company Summary
Table 47. AbbVie Inc Rheumatoid Arthritis Medicine Product Offerings
Table 48. AbbVie Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AbbVie Inc Key News & Latest Developments
Table 50. Hoffman-La Roche AG Company Summary
Table 51. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product Offerings
Table 52. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Hoffman-La Roche AG Key News & Latest Developments
Table 54. Amgen Inc Company Summary
Table 55. Amgen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 56. Amgen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Amgen Inc Key News & Latest Developments
Table 58. Pfizer Inc Company Summary
Table 59. Pfizer Inc Rheumatoid Arthritis Medicine Product Offerings
Table 60. Pfizer Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer Inc Key News & Latest Developments
Table 62. Bristol-Myers Squibb Co Company Summary
Table 63. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product Offerings
Table 64. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bristol-Myers Squibb Co Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Rheumatoid Arthritis Medicine Product Offerings
Table 68. Johnson & Johnson Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. UCB Biosciences Inc Company Summary
Table 71. UCB Biosciences Inc Rheumatoid Arthritis Medicine Product Offerings
Table 72. UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. UCB Biosciences Inc Key News & Latest Developments
Table 74. Mitsubishi Tanabe Pharma Corp Company Summary
Table 75. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product Offerings
Table 76. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Mitsubishi Tanabe Pharma Corp Key News & Latest Developments
Table 78. Biogen Inc Company Summary
Table 79. Biogen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 80. Biogen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Biogen Inc Key News & Latest Developments
Table 82. Merck & Co Company Summary
Table 83. Merck & Co Rheumatoid Arthritis Medicine Product Offerings
Table 84. Merck & Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Merck & Co Key News & Latest Developments
Table 86. Rheumatoid Arthritis Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Rheumatoid Arthritis Medicine Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Rheumatoid Arthritis Medicine Production by Region, 2018-2023 (K Units)
Table 89. Global Rheumatoid Arthritis Medicine Production by Region, 2024-2029 (K Units)
Table 90. Rheumatoid Arthritis Medicine Market Opportunities & Trends in Global Market
Table 91. Rheumatoid Arthritis Medicine Market Drivers in Global Market
Table 92. Rheumatoid Arthritis Medicine Market Restraints in Global Market
Table 93. Rheumatoid Arthritis Medicine Raw Materials
Table 94. Rheumatoid Arthritis Medicine Raw Materials Suppliers in Global Market
Table 95. Typical Rheumatoid Arthritis Medicine Downstream
Table 96. Rheumatoid Arthritis Medicine Downstream Clients in Global Market
Table 97. Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rheumatoid Arthritis Medicine Segment by Type in 2022
Figure 2. Rheumatoid Arthritis Medicine Segment by Application in 2022
Figure 3. Global Rheumatoid Arthritis Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. Rheumatoid Arthritis Medicine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis Medicine Revenue in 2022
Figure 9. By Type - Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 12. By Type - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 16. By Application - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 21. By Country - North America Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 23. US Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 28. Germany Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. France Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 37. China Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. India Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 44. Brazil Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales Market Share, 2018-2029
Figure 48. Turkey Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rheumatoid Arthritis Medicine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Rheumatoid Arthritis Medicine by Region, 2022 VS 2029
Figure 54. Rheumatoid Arthritis Medicine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の関節リウマチ用医薬品市場予測2023-2029：医療用医薬品、一般用医薬品] (コード：MMG23LY8637)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の関節リウマチ用医薬品市場予測2023-2029：医療用医薬品、一般用医薬品]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の睡眠障害治療薬市場予測2023-2029：医療用医薬品、一般用医薬品、漢方薬
  • 世界の下痢止め市場2022年：医療用医薬品、OTC医薬品
  • 世界の胃がん治療市場2022年：処方薬、一般用医薬品
  • 世界の皮膚疾患治療薬市場2022年：処方薬、一般用医薬品
  • 世界の内科用縫合糸市場予測2023-2029：カットグット、再構成コラーゲン、ポリグリコリド、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆